Position in ALNY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$726,084
+$505,725 QoQ
Shares Held
2,412
+262.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#437
of 780 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026111 Capital holds $6,048,567 across 9 Biotechnology names. ALNY ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,185 | $1,985,974 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,080 | $1,529,928 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,412 | $726,084 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
1,839 | $450,132 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
4,826 | $377,731 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,587 | $373,886 | |
| 7 | INCY |
Incyte Corp
|
2,255 | $255,626 | |
| 8 | EXEL |
Exelixis, Inc.
|
4,651 | $253,060 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $726,084 | 2,412 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $220,359 | 666 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $576,990 | 1,451 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||